GCG
IPXL

Giovine Capital Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Giovine Capital Group’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-59,805
Closed -$2.56M – 40
2015
Q4 		$2.56M Sell
59,805
-63,048
-51% -$2.52M 3.72% 6
2015
Q3 		$4.33M Sell
122,853
-3,840
-3% -$173K 3.32% 10
2015
Q2 		$5.82M Buy
+126,693
New +$6.01M 4.12% 3

Other funds holding IPXL

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
HP
Hound Partners New York $792M AUM 9.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return